Ebola drug derived from GM tobacco could cause cancer, elephantiasis and other serious side effects
(NaturalNews) Now that the mainstream media has planted the seeds of fear with regard to the stateside spread of Ebola, the stage is set for the eventual release of Ebola drugs and vaccines to supposedly combat this deadly illness. But experimental drugs already administered to two American aid workers, which contain genetically modified (GM) monoclonal antibodies, pose the threat of cancer, elephantiasis and other serious side effects, according to research.
Known as ZMapp, an experimental Ebola drug containing derivatives of GM tobacco bears resemblances to earlier experimental drugs that used the same technology — and that failed miserably. One experimental drug given to patients at Northwick Park Hospital in London back in 2006 resulted in one man having his head swell, and several others developing signs of cancer.
Three others, according to The Sunday Times, were told that they had an extremely high likelihood of developing incurable autoimmune diseases from the drug, known as TGN1412, which contained GM monoclonal antibodies. The side effects from the drug, made by a Germany-based firm, were so dramatic, in fact, that it was quickly dubbed the “Elephant Man drug,” in reference to a participant whose head essentially blew up.
“Victims of the disastrous ‘Elephant Man’ drugs trial have been told they face contracting cancer and other fatal diseases as a result of being poisoned in the bungled tests,” wrote David Leppard for The Times. “One of the six victims was told last week he is already showing ‘definite early signs’ of lymphatic cancer. … [The men] suffered heart, liver and kidney failure and were left seriously ill.”
Earlier trials on other GM monoclonal antibody drugs had similar outcomes, with patients developing extreme side effects, some of which were permanent. In each case, the experimental drug in question was initially said to have the potential for healing, but once applied to actual humans turned out to have disastrous health consequences, which may also be true for Ebola drugs cut from the same cloth.
GM proteins will always wreak havoc in humans
At no point have GM monoclonal antibodies ever been successful in human trials, as they are, by their very nature, incompatible with the human immune system. Using synthetic proteins that exist nowhere in nature to trigger some kind of positive immune response by the body is human pride and arrogance at its pinnacle — a loathsome attempt at playing God that appears to always result in catastrophic biological damage.
Based on what we already know about GM monoclonal antibody technology, the human body systematically rejects it. Part of this rejection involves damaging the immune system in such a way that it basically attacks itself — this is known as autoimmunity — leading to cellular, organ, and other extreme damage that is typically irreversible
In the case of GM monoclonal antibodies for Ebola, GM tobacco plants are being used as a biological manufacturing facility for the foreign proteins that wreak this type of havoc. A complex process instructs GM tobacco plants to produce the proteins, which are then refined and administered to humans, leading to unknown effects.
“A gene is inserted into a virus that is then used to infect the tobacco plant,” wrote Sharon Begley for Reuters about the process. “The virus acts like a micro-Trojan Horse, ferrying the engineered DNA into the plant.”
“Cells infected with the virus and the gene it is carrying produce the target protein. The tobacco leaves are then harvested and processed to extract the protein, which is purified.”
A full account of the damage potential of GM monoclonal antibodies is available at the Institute of Science in Society: I-SIS.org.uk.
Sources for this article include: